Cambridge Innovation Capital
Venture Capital
Active
Cambridge, United Kingdom
86
35M
42
7.82
16
0.51
3
- Stages of investment
- Areas of investment
Summary
In 2013 was created Cambridge Innovation Capital, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The company was established in Europe in United Kingdom.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cambridge Innovation Capital, startups are often financed by Parkwalk Advisors, Cambridge Angels group, University of Cambridge Enterprise. The meaningful sponsors for the fund in investment in the same round are Amadeus Capital Partners, IQ Capital, Escala Capital. In the next rounds fund is usually obtained by Martlet, Innovate UK, Amadeus Capital Partners.
The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Origami Energy, Gyroscope Therapeutics, Carrick Therapeutics. We can highlight the next thriving fund investment areas, such as Information Technology, Medical Device. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
We also calculated 10 valuable employees in our database.
This Cambridge Innovation Capital works on 25 percentage points less the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 24 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016. The fund is generally included in 7-12 deals every year. The typical startup value when the investment from Cambridge Innovation Capital is 100-500 millions dollars.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- GBP 225000000
- Fund raised date
- 2022-04-25
Analytics
- Total investments
- 86
- Lead investments
- 16
- Exits
- 3
- Rounds per year
- 7.82
- Follow on index
- 0.51
- Investments by industry
- Biotechnology (32)
- Health Care (29)
- Software (21)
- Therapeutics (18)
- Artificial Intelligence (16) Show 58 more
- Investments by region
-
- United Kingdom (76)
- United States (6)
- Ireland (2)
- China (1)
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 64M
- Group Appearance index
- 0.84
- Avg. company exit year
- 7
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Phosphor AI | 04 Jan 2024 | Seed | 2M | Hong Kong, Hong Kong, China | |
Pretzel Therapeutics | 12 Sep 2022 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 72M | United States, Massachusetts, Waltham |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.